EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparison of targeting two antigens (GPA33 versus HER2) for 225 Ac-pretargeted alpha-radioimmunotherapy of colorectal cancer

Sara S Rinne, Daniela Burnes Vargas, Brett A Vaughn, Sumudu Katugampola, Brian W Miller, Darren R Veach, Blesida Punzalan, Elisa de Stanchina, Rona Yaeger, Ileana C Miranda, Hong Xu, Hongfen Guo und 6 weitere

Theranostics · 2025

DOI: 10.7150/thno.116062 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Theranostics, 2025. Verfasst von Sara S Rinne und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Weill Cornell Medicine, New York, NY, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Radioimmunotherapy, Erb-b2 Receptor Tyrosine Kinases, Actinium. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsRadioimmunotherapyErb-b2 Receptor Tyrosine KinasesActiniumAnimalsHumansMiceCell Line, TumorTissue DistributionFemaleXenograft Model Antitumor AssaysDisease Models, AnimalTreatment OutcomeMembrane Glycoproteins

Stichwörter der Autor:innen

Actinium-225glycoprotein A33human epidermal growth factor receptor 2pretargeted radioimmunotherapytargeted alpha therapy

Substanzen

Erb-b2 Receptor Tyrosine KinasesActiniumMembrane GlycoproteinsERBB2 protein, humanActinium-225GPA33 protein, human

Autor:innen und Institutionen

  • Department of Radiology, Weill Cornell Medicine, New York, NY, USA.
  • Department of Pediatrics, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA.
  • Molecular Pharmacology Program, MSKCC, New York, NY, USA.
  • Division of Radiation Research, Department of Radiology and Center for Cell Signaling, New Jersey Medical School, Rutgers University, Newark, NJ, USA.
  • Department of Radiation Oncology, Department of Medical Imaging, College of Medicine, University of Arizona, Tucson, AZ, USA.
  • Department of Radiology, MSKCC, New York, NY, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Rinne, S. S., Vargas, D. B., Vaughn, B. A., Katugampola, S., Miller, B. W., Veach, D. R., Punzalan, B., de Stanchina, E., Yaeger, R., Miranda, I. C., Xu, H., Guo, H., Schwartz, J., Fung, E. K., Howell, R. W., Larson, S. M., Cheung, N. V., & Cheal, S. M. (2025). Comparison of targeting two antigens (GPA33 versus HER2) for 225 Ac-pretargeted alpha-radioimmunotherapy of colorectal cancer. Theranostics. https://doi.org/10.7150/thno.116062

Vancouver

Rinne SS, Vargas DB, Vaughn BA, Katugampola S, Miller BW, Veach DR, et al. Comparison of targeting two antigens (GPA33 versus HER2) for 225 Ac-pretargeted alpha-radioimmunotherapy of colorectal cancer. Theranostics. 2025. doi:10.7150/thno.116062

BibTeX
@article{Rinne2025,
  author = {Rinne, Sara S and Vargas, Daniela Burnes and Vaughn, Brett A and Katugampola, Sumudu and Miller, Brian W and Veach, Darren R and Punzalan, Blesida and de Stanchina, Elisa and Yaeger, Rona and Miranda, Ileana C and Xu, Hong and Guo, Hongfen and Schwartz, Jazmin and Fung, Edward K and Howell, Roger W and Larson, Steven M and Cheung, Nai-Kong V and Cheal, Sarah M},
  title = {Comparison of targeting two antigens (GPA33 versus HER2) for 225 Ac-pretargeted alpha-radioimmunotherapy of colorectal cancer},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.116062}
}
Kostenlos starten →